HCA Healthcare price target raised to $300 from $230 at Raymond James

Raymond James analyst John Ransom raised the firm’s price target on HCA Healthcare to $300 from $230 and keeps an Outperform rating on the shares. HCA’s Q4 results were in line with Street expectations, and while the initial guidance was below expectations, constructive commentary on labor and volumes fueled a rebound with the stock trading roughly flat over the last two trading days, the analyst tells investors in a research note.